Terremoto Biosciences will get $75M to Develop Covalent Medicines
San Francisco-based Terremoto Biosciences launched with $75 million in Sequence A financing to develop extremely
Biosciences
Isracann Biosciences Indicators Definitive Settlement to Purchase Pure Well being Drugs Developer
Isracann Biosciences Inc. VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc.